Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease

Cleveland, NK; Masching, A; Rubin, DT

ACG CASE REPORTS JOURNAL, 2020; 7 (8):

Abstract

Ustekinumab is a monoclonal antibody against the p40 subunit of interleukin (IL)-12 and IL-23 and is US Food and Drug Administration (FDA)-approved fo......

Full Text Link